Category: Medicines

Gluformin G 1 Forte New Tablet PR is an oral anti-diabetic medicine used for the effective management of Type 2 Diabetes Mellitus. It combines two powerful anti-diabetic agents: Glimepiride, a sulfonylurea that stimulates the pancreas to release more insulin, and Metformin, a biguanide that reduces glucose production in the liver and improves the body’s sensitivity to insulin. The “PR” in the name indicates prolonged release, which ensures a gradual release of medicine for better blood sugar control throughout the day.

This dual-action therapy is particularly useful in patients where blood sugar is not adequately controlled with Metformin or Glimepiride alone. By targeting different mechanisms, it helps lower fasting and post-meal glucose levels and prevents complications of diabetes.

---

Uses:

• Management of Type 2 Diabetes Mellitus (T2DM)

• Helps in controlling high blood sugar levels

• Reduces risk of diabetes-related complications such as kidney damage, vision problems, nerve damage, heart disease, and stroke

• Often prescribed when diet, exercise, and single-drug therapy are insufficient

---

Dosage & Administration:

• Taken orally with food, usually once daily or as prescribed by the doctor.

• Dose may vary depending on blood sugar levels and medical condition.

• Swallow the tablet whole; do not crush or chew (as it is prolonged release).

• Regular blood sugar monitoring is recommended during treatment.

---

Mechanism of Action:

• Glimepiride (1mg): Stimulates pancreatic beta cells to release more insulin, lowering blood glucose.

• Metformin (1000mg): Decreases glucose production in the liver, delays glucose absorption from the intestines, and improves insulin sensitivity.
  Together, they provide complementary control of blood sugar.

---

Side Effects:

Like all medicines, it may cause some side effects, although not everyone gets them.

• Common: Nausea, diarrhea, stomach upset, headache, weakness, dizziness.

• Moderate: Weight gain, low blood sugar (hypoglycemia) with symptoms like sweating, tremors, hunger, blurred vision.

• Serious (rare):

  • Lactic acidosis (due to Metformin) – symptoms include severe weakness, muscle pain, irregular heartbeat, difficulty breathing.

  • Severe hypoglycemia.

  • Liver dysfunction or jaundice.

---

Precautions:

• Not suitable for Type 1 Diabetes or patients with diabetic ketoacidosis.

• Use with caution in patients with kidney or liver disease.

• Avoid excessive alcohol consumption, as it increases the risk of lactic acidosis.

• Pregnant or breastfeeding women should use only if clearly advised by a doctor.

• Inform your doctor if taking other anti-diabetic medicines, blood pressure medicines, or steroids.

---

Storage:

• Store in a cool, dry place below 25°C.

• Keep away from direct sunlight and moisture.

• Keep out of reach of children.

Gluformin XL New 1000 Tablet is an extended-release oral antidiabetic medicine containing Metformin Hydrochloride (1000mg). It belongs to the class of biguanides and is primarily prescribed for the management of Type 2 Diabetes Mellitus (T2DM).

The XL (extended-release) formulation ensures a slow and steady release of Metformin into the bloodstream, providing prolonged blood glucose control and minimizing gastrointestinal side effects compared to immediate-release tablets.

Metformin acts by reducing excess glucose production in the liver (hepatic gluconeogenesis), slowing the absorption of glucose from the intestines, and improving insulin sensitivity in muscle and fat cells. It helps maintain normal blood sugar levels and lowers the risk of long-term diabetes-related complications.

---

Uses:

• First-line treatment for Type 2 Diabetes Mellitus (T2DM).

• Helps in lowering fasting plasma glucose (FPG) and postprandial glucose (PPG) levels.

• Improves overall glycemic control and aids in HbA1c reduction.

• Reduces the risk of macrovascular and microvascular complications (heart attack, stroke, neuropathy, nephropathy, and retinopathy).

• May assist in weight management and improving lipid profile in some patients.

---

Dosage & Administration:

• Typically prescribed once daily with an evening meal or as advised by the physician.

• Should be swallowed whole without crushing or chewing to maintain the extended-release property.

• Dose adjustment is based on blood glucose monitoring, HbA1c levels, and patient tolerance.

---

Mechanism of Action:

• Reduces hepatic glucose output: Inhibits gluconeogenesis in the liver.

• Delays intestinal glucose absorption: Slows down uptake of sugar from food.

• Increases insulin sensitivity: Enhances peripheral glucose uptake and utilization.

This multi-target action helps in achieving stable blood sugar control without causing excessive insulin secretion.

---

Side Effects:

• Common: Nausea, vomiting, abdominal discomfort, diarrhea, metallic taste.

• Less common: Loss of appetite, mild weakness, dizziness.

• Rare but serious:

  • Lactic acidosis (life-threatening but very rare) – symptoms include extreme tiredness, irregular heartbeat, muscle pain, or breathing difficulty.

  • Vitamin B12 deficiency with long-term use.

---

Precautions:

• Not recommended in Type 1 Diabetes or diabetic ketoacidosis.

• Contraindicated in patients with severe kidney disease (eGFR <30 ml/min/1.73 m²).

• Should be used cautiously in patients with liver disease, heart failure, or alcohol dependency.

• Avoid alcohol intake to reduce the risk of lactic acidosis.

• Pregnant and breastfeeding women should take only if advised by a doctor.

• Regular monitoring of kidney function, liver function, and Vitamin B12 levels is recommended during long-term use.

---

Storage:

• Store in a cool, dry place, below 25°C.

• Protect from light and moisture.

• Keep out of reach of children.

GLYCELIPTIN-M FORTE is an oral antidiabetic combination tablet containing teneligliptin (DPP-4 inhibitor) and metformin (sustained release). It is used to treat type 2 diabetes mellitus, particularly in patients whose blood sugar is inadequately controlled by metformin alone or as an initial dual therapy.

How GLYCELIPTIN-M FORTE Works

• Metformin (1000 mg SR): Lowers glucose production in the liver, increases insulin sensitivity, and improves peripheral glucose uptake.

• Teneligliptin (20 mg): Increases incretin hormone levels, which stimulate insulin release and suppress glucagon after meals, resulting in improved blood sugar control, especially postprandially.

Uses

• Type 2 diabetes mellitus: For adults as part of a comprehensive diabetes management plan (alongside diet and exercise) to control blood glucose and reduce the risk of complications.

• Used as monotherapy when dual action is needed or as step-up/add-on therapy to existing antidiabetic regimens.

Benefits

• Provides more effective HbA1c and blood sugar reduction compared to monotherapy.

• Convenient once-daily dosing with sustained-release metformin for prolonged glucose control

• Lower risk of hypoglycemia and weight gain versus many older antidiabetics.

Common Side Effects

• Nausea, diarrhea, upset stomach, headache, and vomiting.

• Low blood sugar (more likely if used with sulfonylureas or insulin)

• Rare: Lactic acidosis (in severe kidney/liver/heart disease), vitamin B12 deficiency, allergic rash

Directions & Safety Advice

• Take with meals to reduce GI side effects; do not chew or crush sustained-release tablets.

• Not for use in type 1 diabetes, pregnancy/breastfeeding without physician advice, or people with severe renal/hepatic impairment.

• Continue diet, exercise, and regular blood sugar monitoring for best results

• Avoid alcohol and inform your doctor about any other medications and health conditions

GLYCELIPTIN-M FORTE is a prescription combination for type 2 diabetes that is widely available in India and is not subject to any bans or restrictions.

Grandem 1 Tablet contains Granisetron (1mg), a selective 5-HT3 receptor antagonist used to prevent and treat nausea and vomiting. These symptoms are often associated with chemotherapy, radiotherapy, and surgical procedures. By blocking serotonin activity in the gut and brain, it effectively reduces the vomiting reflex.

---

Uses / Indications

• Chemotherapy-induced nausea and vomiting (CINV)

• Radiotherapy-induced nausea and vomiting (RINV)

• Post-operative nausea and vomiting (PONV)

---

How It Works

• During cancer treatments or surgery, the body releases serotonin in the gut.

• Serotonin activates 5-HT3 receptors, which send signals to the brain to induce vomiting.

• Granisetron blocks these receptors, thereby preventing and controlling nausea and vomiting.

---

Dosage & Administration

• Adults (oral use): Usually 1mg tablet taken 1 hour before chemotherapy or radiotherapy, may be repeated as advised.

• Can also be given before and after surgery to prevent post-operative vomiting.

• Swallow the tablet with water, with or without food.

• The exact dosage and duration should be decided by the doctor based on treatment type, patient’s age, and body weight.

Note:

• Do not self-medicate or change the dose.

• Use in children should be under pediatric supervision only.

---

Side Effects

Common:

• Headache

• Constipation

• Diarrhea

• Fatigue or drowsiness

Less common:

• Dizziness

• Abdominal pain

• Insomnia (sleep disturbances)

Serious (rare):

• Allergic reaction (rash, swelling, breathing difficulty)

• Irregular heart rhythm (QT prolongation)

• Severe constipation

---

Precautions & Warnings

• Not to be used if allergic to Granisetron or similar medicines like Ondansetron.

• Caution in patients with heart problems, electrolyte imbalance, or liver disease.

• Pregnant or breastfeeding women should use only if prescribed.

• May cause drowsiness or dizziness – avoid driving or operating heavy machinery until effects are known.

---

Summary

Grandem 1 Tablet (Granisetron 1mg) is a reliable antiemetic for preventing and treating nausea and vomiting caused by chemotherapy, radiation therapy, or surgery. It is generally well tolerated and effective when taken as prescribed by a healthcare professional.

Grandem Injection contains Granisetron (1 mg), a serotonin 5-HT3 receptor antagonist used to prevent and treat nausea and vomiting caused by chemotherapy, radiotherapy, or surgery. It works by blocking serotonin, a natural substance in the body that triggers the vomiting reflex. This medicine is usually administered in a hospital or clinical setting under medical supervision.

---

Uses / Indications

• Prevention and treatment of chemotherapy-induced nausea and vomiting (CINV)

• Prevention and treatment of radiotherapy-induced nausea and vomiting

• Prevention and treatment of post-operative nausea and vomiting (PONV)

---

How It Works (Mechanism of Action)

• Granisetron (1 mg): Selectively blocks 5-HT3 receptors located in the brain and gastrointestinal tract.

• Prevents serotonin from binding to these receptors, thereby suppressing the vomiting reflex.

• Provides effective relief from nausea and vomiting associated with cancer treatments and surgical procedures.

---

Dosage & Administration

• Given intravenously (IV) by a doctor or nurse.

• Chemotherapy-induced nausea/vomiting: Usually administered before and/or after chemotherapy.

• Surgery-related nausea/vomiting: Administered before induction of anesthesia or after surgery if nausea occurs.

• Dose and frequency are determined by the doctor depending on the patient’s condition, type of chemotherapy/surgery, and response.

---

Side Effects

Common:

• Headache

• Constipation

• Diarrhea

• Weakness or fatigue

Less common:

• Dizziness

• Trouble sleeping

• Injection site reactions (pain, redness, swelling)

Serious (rare):

• Allergic reactions (rash, itching, swelling of face/lips, difficulty breathing)

• Heart rhythm disturbances (QT prolongation, palpitations)

• Severe abdominal pain or persistent constipation

---

Precautions & Warnings

• Should only be administered under medical supervision.

• Caution in patients with heart disease or arrhythmias.

• Inform doctor if taking other medicines that affect heart rhythm (e.g., antiarrhythmics, antidepressants).

• Safe use in pregnancy and breastfeeding has not been fully established – use only if prescribed.

• Not recommended for patients with known hypersensitivity to Granisetron or other 5-HT3 antagonists.

---

Summary

Grandem Injection (Granisetron 1 mg) is an effective anti-nausea medicine used to prevent and manage nausea and vomiting associated with chemotherapy, radiotherapy, and surgical procedures. It is generally well-tolerated, but requires hospital/clinical administration and monitoring for possible side effects like headache, constipation, or heart rhythm changes.